CASP3 and diabetes mellitus: The increased apoptosis in bone linked to diabetes is significant since inhibiting apoptosis with a caspase-3 inhibitor or a TNF inhibitor results in significantly enhanced tissue formation in diabetic animals (9, 47, 48).